A phase II study of epirubicin in breast cancer.
el Mawla NG, Hamza MR, el Khodari A, Khaled H, Gaafar R, el Zawahry H, abdel Wareth A, Dardir MD, Habboubi N.
el Mawla NG, et al. Among authors: dardir md.
Anticancer Drugs. 1991 Aug;2(4):371-4. doi: 10.1097/00001813-199108000-00006.
Anticancer Drugs. 1991.
PMID: 1797193
Clinical Trial.